Cardiologists should care about glucose: most people with CV disease or risk factors have diabetes or significant glycaemic abnormalities. Results of screening over 39,000 subjects for NAVIGATOR

Míreanna comhchosúla

• Association of non-alcoholic steatothepatitis with components of the metabolic syndrome in 43,509 patients screened for NAVIGATOR
  de réir: Bethel, A, et al.
  Foilsithe / Cruthaithe: (2005)
• Determining the most appropriate components for a composite clinical trial outcome.
  de réir: Bethel, M, et al.
  Foilsithe / Cruthaithe: (2008)
• Parallel Evolution in <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content> over 39,000 Generations <italic toggle="yes">In Vivo</italic>
  de réir: Holly K. Huse, et al.
  Foilsithe / Cruthaithe: (2010-10-01)
• Prediabetes and the risk of diabetes.
  de réir: McMurray, J, et al.
  Foilsithe / Cruthaithe: (2012)
• Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
  de réir: Califf, R, et al.
  Foilsithe / Cruthaithe: (2008)